Laman Utama500257 • BOM
add
Lupin Ltd
Tutup sebelumnya
₹2,356.85
Julat hari
₹2,301.00 - ₹2,364.05
Julat tahun
₹1,774.00 - ₹2,376.00
Permodalan pasaran
1.06T INR
Bilangan Purata
26.42K
Nisbah P/E
21.31
Hasil dividen
0.52%
Pertukaran utama
NSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 71.68B | 24.27% |
Perbelanjaan pengendalian | 33.93B | 18.38% |
Pendapatan bersih | 11.76B | 37.47% |
Margin untung bersih | 16.40 | 10.59% |
Pendapatan bagi setiap syer | 32.18 | 72.18% |
EBITDA | 21.20B | 52.17% |
Kadar cukai berkesan | 22.44% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 62.82B | 115.71% |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 197.28B | — |
Syer tertunggak | 456.70J | — |
Harga kepada buku | 5.48 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 18.27% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 11.76B | 37.47% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia.. Wikipedia
Diasaskan
1968
Ibu pejabat
Tapak web
Pekerja
24,006
